Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Assembly Biosciences (ASMB) over the last 14 years, with Dec 2024 value amounting to -$40.2 million.

  • Assembly Biosciences' Net Income towards Common Stockholders rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.2 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of -$40.2 million for FY2024, which is 34.38% up from last year.
  • Latest data reveals that Assembly Biosciences reported Net Income towards Common Stockholders of -$40.2 million as of FY2024, which was up 34.38% from -$61.2 million recorded in FY2023.
  • Assembly Biosciences' Net Income towards Common Stockholders' 5-year high stood at -$40.2 million during FY2024, with a 5-year trough of -$129.9 million in FY2021.
  • In the last 3 years, Assembly Biosciences' Net Income towards Common Stockholders had a median value of -$61.2 million in 2023 and averaged -$64.8 million.
  • As far as peak fluctuations go, Assembly Biosciences' Net Income towards Common Stockholders surged by 36.34% in 2020, and later crashed by 108.93% in 2021.
  • Over the past 5 years, Assembly Biosciences' Net Income towards Common Stockholders (Yearly) stood at -$62.2 million in 2020, then tumbled by 108.93% to -$129.9 million in 2021, then grew by 28.31% to -$93.1 million in 2022, then spiked by 34.23% to -$61.2 million in 2023, then soared by 34.38% to -$40.2 million in 2024.